443 related articles for article (PubMed ID: 20417189)
1. The benefits and challenges associated with the use of drug delivery systems in cancer therapy.
Cukierman E; Khan DR
Biochem Pharmacol; 2010 Sep; 80(5):762-70. PubMed ID: 20417189
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Updates on the use of liposomes for active tumor targeting in cancer therapy.
Yan W; Leung SS; To KK
Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
[TBL] [Abstract][Full Text] [Related]
4. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
5. The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes.
Ahmed SE; Martins AM; Husseini GA
J Drug Target; 2015 Jan; 23(1):16-42. PubMed ID: 25203857
[TBL] [Abstract][Full Text] [Related]
6. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
[TBL] [Abstract][Full Text] [Related]
7. Active targeting strategies for anticancer drug nanocarriers.
Basile L; Pignatello R; Passirani C
Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
9. Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites.
Cao J; Huang D; Peppas NA
Adv Drug Deliv Rev; 2020 Dec; 167():170-188. PubMed ID: 32622022
[TBL] [Abstract][Full Text] [Related]
10. Organic nanocarriers for cancer drug delivery.
López-Dávila V; Seifalian AM; Loizidou M
Curr Opin Pharmacol; 2012 Aug; 12(4):414-9. PubMed ID: 22465543
[TBL] [Abstract][Full Text] [Related]
11. Liposomes. Opportunities in drug delivery.
Allen TM
Drugs; 1997; 54 Suppl 4():8-14. PubMed ID: 9361956
[TBL] [Abstract][Full Text] [Related]
12. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
Tanbour R; Martins AM; Pitt WG; Husseini GA
Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine in cancer therapy: innovative trends and prospects.
Blanco E; Hsiao A; Mann AP; Landry MG; Meric-Bernstam F; Ferrari M
Cancer Sci; 2011 Jul; 102(7):1247-52. PubMed ID: 21447010
[TBL] [Abstract][Full Text] [Related]
14. Emerging Strategies and Challenges for Controlled Delivery of Taxanes: A Comprehensive Review.
Mahajan M; Khurana RK; Sahajpal NS; Utreja P; Sankar R; Singh B; Jain SK
Curr Drug Metab; 2015; 16(6):453-73. PubMed ID: 26264203
[TBL] [Abstract][Full Text] [Related]
15. Polymeric micelles in anticancer therapy: targeting, imaging and triggered release.
Oerlemans C; Bult W; Bos M; Storm G; Nijsen JF; Hennink WE
Pharm Res; 2010 Dec; 27(12):2569-89. PubMed ID: 20725771
[TBL] [Abstract][Full Text] [Related]
16. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
Belfiore L; Saunders DN; Ranson M; Thurecht KJ; Storm G; Vine KL
J Control Release; 2018 May; 277():1-13. PubMed ID: 29501721
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle technologies for cancer therapy.
Alexis F; Pridgen EM; Langer R; Farokhzad OC
Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
[TBL] [Abstract][Full Text] [Related]
18. Passive and active drug targeting: drug delivery to tumors as an example.
Torchilin VP
Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
[TBL] [Abstract][Full Text] [Related]
19. Dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer.
El-Tanani M; Nsairat H; Aljabali AA; Matalka II; Alkilany AM; Tambuwala MM
Expert Opin Drug Deliv; 2024 Feb; 21(2):309-324. PubMed ID: 38284386
[TBL] [Abstract][Full Text] [Related]
20. Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy.
Bhatia R; Sharma A; Narang RK; Rawal RK
Curr Mol Pharmacol; 2021; 14(3):350-366. PubMed ID: 32744982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
